Informação sobre produto
RIPGBMNew is a recombinant human protein that is a potential drug target for cancer. It contains a kinase domain that interacts with RIPK1 and RIPK3, which are important for the activation of the cell death pathway. The RIPGBMNew molecule has been shown to be able to induce apoptosis in various types of cancer cells by inhibiting the kinase activity of these two proteins. In addition, this molecule interacts with other proteins involved in cell death pathways, such as BAX and BAK, and can also induce apoptosis through activation of caspases. Strategies for developing drugs that inhibit the kinase activity of RIPK1 or RIPK3 are being investigated. One strategy involves developing chimeric antigen receptors (CARs) that have an extracellular domain that binds to the surface protein CD19 and an intracellular domain that inhibits the kinase activity of RIPK1 or RIPK3. The use of CARs in clinical trials has been shown to
Propriedades químicas
Consulta técnica sobre: 3D-FPA40676 RIPGBMNew
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
